Modulation of surface expression of human platelet prostacyclin receptors by cholesterol, dibucaine and pentoxifylline.
Funck
M
M
Medizinische Klinik, Universität Tübingen, FRG.
Muller
C P
CP
Jaschonek
K
K
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002784:Cholesterol / Q000494:pharmacology*; D003992:Dibucaine / Q000494:pharmacology*; D011464:Epoprostenol / Q000097:blood*; D006801:Humans; D016285:Iloprost; D010431:Pentoxifylline / Q000494:pharmacology*; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin / Q000187:drug effects*; D013805:Theobromine / Q000031:analogs & derivatives*
D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin; D002784:Cholesterol; D011464:Epoprostenol; D016285:Iloprost; D003992:Dibucaine; D013805:Theobromine; D010431:Pentoxifylline